| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 06/11/2002 | US6403358 21529, a novel adenylate cyclase |
| 06/11/2002 | US6403357 Thermostable D-hydantoinase and the application thereof |
| 06/11/2002 | US6403356 Mutant penicillin G acylases |
| 06/11/2002 | US6403355 Amylases |
| 06/11/2002 | US6403354 Dna from bacillus; genetic engineering |
| 06/11/2002 | US6403353 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 06/11/2002 | US6403352 Compositions and methods for production of male-sterile plants |
| 06/11/2002 | US6403351 Regenerates oxaloacetate consumed during lysine and glutamic acid production in industrial fermentation ; amino acid sequence |
| 06/11/2002 | US6403350 Method for rapidly obtaining enzyme crystals with desirable morphologies |
| 06/11/2002 | US6403349 Elongation of polyunsaturated fatty acid such as linolenic acid to dihomogamma linolenic acid; nucleotide sequence encodes polypeptide; genetic engineering; animal feeds, nutrients, cosmetics |
| 06/11/2002 | US6403344 Acetylation of lecithin or phosphatidylethanolamine with vinyl acetate in presence of lipase catalyst; amidation, separation |
| 06/11/2002 | US6403342 DNA coding for mutant isopropylmalate synthase L-leucine-producing microorganism and method for producing L-leucine |
| 06/11/2002 | US6403331 Mutant proteolytic enzymes and method of production |
| 06/11/2002 | US6403330 Used in therapy and prophylaxis of degenerative conditions resulting in increased bone resorption, such as tissue damages, bone metabolic disorders, osteoporosis |
| 06/11/2002 | US6403312 Protein design automatic for protein libraries |
| 06/11/2002 | US6403310 Human inositol monophosphatase H1 |
| 06/11/2002 | US6403306 Detection and diagnosis of meningococcal strains; vaccines with capsular polysaccharide conjugates; genetic engineering |
| 06/11/2002 | US6403304 Human osteoclast-specific and -related DNA sequences |
| 06/11/2002 | US6403299 Transforming non-leflunomide resistant cell with dna sequence encoding deah box protein that binds atp and nucleic acid; culturing; modulating helicase activity; genetic engineering |
| 06/11/2002 | US6403089 Inhibitors of fgl2; bacterial and viral infections, allograft and xenograft rejection, glomerulonephritis, cancer, gastrointestinal diseases and fetal loss; monoclonal and polyclonal antibodies which bind to fgl2 and prevent fibrin |
| 06/11/2002 | US6403081 Generating immunology response |
| 06/11/2002 | US6402899 Process for intercalation of spacer molecules between substrates and active biomolecules |
| 06/11/2002 | CA2194375C Chondroitin lyase enzymes |
| 06/11/2002 | CA2152266C Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/turyosinase peptide antigens |
| 06/11/2002 | CA1341367C Enhanced production of proteins by cell culture |
| 06/08/2002 | CA2375097A1 Compositions and methods for identifying and distinguishing orthosomycin biosynthetic loci |
| 06/06/2002 | WO2002044731A2 Use of intramolecularly, covalently cross-linked proteins as binding partners in immunoassays |
| 06/06/2002 | WO2002044722A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 06/06/2002 | WO2002044409A2 Substrate linked directed evolution (slide) |
| 06/06/2002 | WO2002044393A1 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |
| 06/06/2002 | WO2002044392A2 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence programmed and cell death in plants |
| 06/06/2002 | WO2002044387A1 Novel fructosyl amino acid oxidase |
| 06/06/2002 | WO2002044385A1 Gene encoding acetolactic acid synthase gene |
| 06/06/2002 | WO2002044360A2 Modified arginine deiminase |
| 06/06/2002 | WO2002044359A1 Enzyme with proteolytic activity |
| 06/06/2002 | WO2002044358A2 Methods and compositions for diagnosis and treatment of cancer using arginine m ethyltransferase 3 |
| 06/06/2002 | WO2002044357A2 Methods of using 18903 to treat pain and pain-related disorders |
| 06/06/2002 | WO2002044356A2 25206, a novel human short-chain dehydrogenase/reductase family member and uses thereof |
| 06/06/2002 | WO2002044355A2 Protozoan expression systems for lysosomal storage disease genes |
| 06/06/2002 | WO2002044353A2 Human heparanase gene regulatory sequences |
| 06/06/2002 | WO2002044352A1 Bacteriolytic complex, method for producing said complex and strain for carrying out said method. |
| 06/06/2002 | WO2002044351A2 Regulation of human fatty acid coa ligase |
| 06/06/2002 | WO2002044350A2 Cyclodextrin glucanotransferase (cgtase), obtained from bacillus agaradherens (dsm 9948) and detergents and cleaning agents containing said novel cyclodextrin glucanotransferase |
| 06/06/2002 | WO2002044349A2 INCORPORATION AND PRIMING FUNCTION OF tRNALYS IN HIV AND RELATED VIRUSES |
| 06/06/2002 | WO2002044347A1 A virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it |
| 06/06/2002 | WO2002044335A2 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions |
| 06/06/2002 | WO2002044331A2 Dap-kinase and hoxa9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer |
| 06/06/2002 | WO2002044328A2 Anti-angiogenic polypeptides |
| 06/06/2002 | WO2002044320A2 Human elongase genes and uses thereof |
| 06/06/2002 | WO2002044213A1 New cytochrome p450 proteins and the corresponding dna sequences |
| 06/06/2002 | WO2002043745A2 Histaminase of vegetable origin for use in the treatment of allergic and septic shock and of allergic asthma |
| 06/06/2002 | WO2002043741A2 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 06/06/2002 | WO2002024941A3 Protein kinase regulation |
| 06/06/2002 | WO2002020726A3 Method for increasing the effectiveness of antiinfective agents |
| 06/06/2002 | WO2002016547A3 Subtilase enzymes |
| 06/06/2002 | WO2002000855A3 Regulation of human s-acyl fatty acid synthase thioesterase-like enzyme |
| 06/06/2002 | WO2001098340A3 Regulation of human mast cell protease 6-like enzyme |
| 06/06/2002 | WO2001096542A3 A human aminotransferase (23680) and uses thereof |
| 06/06/2002 | WO2001096538A3 Regulation of human transmembrane serine protease |
| 06/06/2002 | WO2001090334A3 Drug metabolizing enzymes |
| 06/06/2002 | WO2001090331A3 C1 bacteriophage lytic system |
| 06/06/2002 | WO2001090329A3 A novel human acyltransferase family member and uses thereof |
| 06/06/2002 | WO2001090125A3 Haplotypes of the pdxk gene |
| 06/06/2002 | WO2001079472A3 Nucleic acid sequences to proteins involved in tocopherol synthesis |
| 06/06/2002 | WO2001079466A3 Regulation of human epithin-like serine protease |
| 06/06/2002 | WO2001079442A3 Albumin fusion proteins |
| 06/06/2002 | WO2001075009A3 A novel polypeptide, arnt synthetase serine 27 and the polynucleotide encoding the polypeptide |
| 06/06/2002 | WO2001074999A3 A novel polypeptide - short chain dehydrogenase/reductase 14 and the polynucleotide encoding said polypeptide |
| 06/06/2002 | WO2001074998A3 Novel polypeptide - a human protein hydrolytic enzyme regulatory protein 10 and polynucleotide encoding it |
| 06/06/2002 | WO2001074768A3 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 06/06/2002 | WO2001072973A3 Regulation of human heparanase-like enzyme |
| 06/06/2002 | WO2001066756A9 22105, a human thioredoxin family member and uses thereof |
| 06/06/2002 | WO2001064907A3 Lipid metabolism enzymes |
| 06/06/2002 | WO2001040504A3 Methods and compositions for detecting nitroaromatic compounds |
| 06/06/2002 | WO2001036645A3 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same |
| 06/06/2002 | WO2001032922A3 Methods for detection of a target nucleic acid sequence |
| 06/06/2002 | WO2001023524A8 Membrane type serine protease 1 (mt-sp1) and uses thereof |
| 06/06/2002 | WO2001021810B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/06/2002 | WO2000024782A3 Modified peptides, comprising an fc domain, as therapeutic agents |
| 06/06/2002 | US20020069433 Amplifying reproduction of preferential plants; obtain cells, transform, express vector, propagate plant, monitor enzymatic activity of plant |
| 06/06/2002 | US20020069432 Signal transduction stress-related proteins and methods of use in plants |
| 06/06/2002 | US20020069431 Effect of endochitinase and chitobiosidase and their encoding genes on plant growth and development |
| 06/06/2002 | US20020069430 Transgenic plants that exhibit enhanced nitrogen assimilation |
| 06/06/2002 | US20020069429 Method for conferring herbicide, pest, or disease resistance in plant hosts |
| 06/06/2002 | US20020068860 Comprises glucose oxidase emulsion with perfluorocarbon which is used with miniature polarographic device; gels |
| 06/06/2002 | US20020068823 33877 and 47179, novel human glycosyltransferase family members and uses thereof |
| 06/06/2002 | US20020068713 Genetic engineering of vascular grafts to resist disease |
| 06/06/2002 | US20020068706 Inhibitors of cyclin-dependent kinases (CDKs), particularly CDK/cyclin complexes, can be used to control proliferation and/or differentiation of cells |
| 06/06/2002 | US20020068698 13237, 18480, 2245 or 16228 novel human protein kinase molecules and uses therefor |
| 06/06/2002 | US20020068691 Breast specific gene or "BSGs" consisting of specific nucleotide sequences and proteins expressed by these gene; vaccine for prevention of breast cancer |
| 06/06/2002 | US20020068359 Nucleotide sequences coding regulatory sequences; for use in generating genetically engineered plant |
| 06/06/2002 | US20020068354 Genetically engineering hematopoietic progenitor cells; obtain cells, transform with vector, monitor cells for expression of vector proteins |
| 06/06/2002 | US20020068352 Alpha-amylase variants with altered 1, 6-activity |
| 06/06/2002 | US20020068351 Nucleotide sequences coding enzymatic polypeptide for use as antidepressant, antiasthmatic or anti-inflammatory agent |
| 06/06/2002 | US20020068350 Enzymatic polypeptide for use in nutrients of animal feeds |
| 06/06/2002 | US20020068349 Nucleotide sequences coding enzymatic polypeptide for use in the generation of trehalose |
| 06/06/2002 | US20020068348 42755, a novel human methyltransferase family member and uses thereof |
| 06/06/2002 | US20020068347 Membrane protein for use in the diagnosis and prevention of cancer |
| 06/06/2002 | US20020068346 Enzymatic polypeptide for use in the prevention and treatment of viral diseases |
| 06/06/2002 | US20020068341 Human kallikrein |